GenomiCare Biotechnology, based in both China and the United States, is an innovative, patient-centered biotech company bringing real-world oncology solutions to global pharma and biotech companies to develop cutting-edge cancer therapeutics to Chinese patients with optimized market access. Since 2015 and across a network of 1,200+ physicians in 200+ hospitals, GenomiCare has been guiding thousands of Chinese cancer patients towards precision oncology treatment and disease management through integration of longitudinal patient records across multiple institutions and deep in-house sequencing capabilities.